Moderate to Severe Asthma Perspective

• Key Asthma Abstracts From AAAAI 2023   Key data from AAAAI 2023 highlight the impact of biologics on exacerbations, systemic corticosteroid use on healthcare resource utilization, patients starting dupilumab, and disparities in asthma treatment.
  Medscape, March 20, 2023
• AAAAI 2023 Read clinically focused news coverage of key developments from AAAAI 2023.
  Medscape Allergy & Immunology, February 24, 2023
• Episode 6: Challenges and Opportunities: Moderate to Severe Childhood Asthma   Drs Wechsler, Bacharier, and Phipatanakul discuss the challenges and opportunities in the field of moderate to severe childhood asthma.
  Medscape, December 06, 2022
• Highlights in Asthma Therapy From CHEST 2022   From CHEST 2022, Dr Navitha Ramesh reports key data on biologic therapies for asthma patients, including results from the CLEAR study and trials on omalizumab, benralizumab, and tezepelumab.
  Medscape, November 09, 2022
• Episode 5: How Do Smoking, Rats, and Violence Affect Asthma?   What are the social and environmental determinants of asthma? Drs Wechsler, Cardet, and Kraft have a wide-ranging discussion about the science, publications, and their experience as clinicians.
  Medscape, November 02, 2022
• Episode 4: Team Effort: Multidisciplinary Approach to Severe Asthma   Drs Wechsler and Jackson discuss their partnerships with nurses, asthma educators, psychologists, speech therapists, and other specialists when diagnosing and treating patients with severe asthma.
  Medscape, October 04, 2022
• Episode 3: Novel Therapies in Severe Asthma Treatment   Drs Wechsler and Akuthota discuss novel therapies in severe asthma treatment, including precision medicine, biomarkers, and new biologic agents.
  Medscape, September 07, 2022
• Episode 2: Asthma Clinical Trials and Precision Medicine   Drs Michael Wechsler and Mario Castro discuss precision medicine for moderate to severe asthma and the past, present, and future of clinical trials.
  Medscape, August 04, 2022
• Episode 1: Challenges and Opportunities: Precision Medicine in Asthma   Listen in as Drs Michael Wechsler and Geoffrey Chupp discuss real-world examples of how they use precision medicine in their own clinics to treat moderate to severe asthma.
  Medscape, August 04, 2022
• Updates in Moderate to Severe Asthma From AAAAI 2022   Dr Tara Carr offers updates on the impact of COVID-19 and social disparities on asthma care, and the role of disease phenotypes in predicting severity, from AAAAI 2022.
  Medscape, March 18, 2022
• AAAAI 2022 Read clinically focused news coverage of key developments from AAAAI 2022
  Medscape Allergy & Immunology, February 28, 2022
• Asthma Highlights From ACAAI 2021   From ACAAI 2021, Dr Sandhya Khurana reports on advances in asthma, including novel biologic therapies, burden of corticosteroid use, and racial differences in late effects of COVID-19.
  Medscape, November 30, 2021
• Air Supply: Targeting Eosinophils in Severe Asthma: Throwing up Roadblocks   Clinicians discuss the use of monoclonal antibodies in eosinophilic asthma, their benefits and drawbacks, and the importance of ongoing patient education.
  Medscape TV, November 29, 2021
• Top Asthma Findings From CHEST 2021   From CHEST 2021, Dr Mario Castro reports on advances in asthma, including efficacy of a novel biologic therapy, improved outcomes with dupilumab, and data on the effect of cannabis in asthma patients.
  Medscape, November 10, 2021
• Air Supply: Targeting Eosinophils in Severe Asthma: Life on Steroids   Leading pulmonologists discuss the consequences of long-term steroid use in the treatment of severe asthma, and a patient describes the burden of such therapy.
  Medscape TV, September 29, 2021
• Air Supply: Targeting Eosinophils in Severe Asthma: Airtight   Asthma specialists and a patient with severe eosinophilic asthma describe the pathophysiology and the experience of an acute exacerbation.
  Medscape TV, July 27, 2021
• Air Supply: Targeting Eosinophils in Severe Asthma   Leading pulmonologists discuss how the identification of eosinophilic subtypes has led to improved asthma management and development of new therapies for patients with severe asthma.
  Medscape TV, May 06, 2021
• Severe Asthma Highlights From AAAAI 2021   Dr Mario Castro reviews key studies on severe asthma presented at the virtual 2021 American Academy of Allergy, Asthma & Immunology (AAAAI) meeting, including the phase 3 NAVIGATOR trial.
  Medscape, March 19, 2021
• AAAAI 2021 Read clinically focused news coverage of key developments from AAAAI 2021
  Medscape Allergy & Immunology, February 27, 2021
• Big, Important Changes in Asthma Management Guidelines   Dr Neil Skolnik summarizes the most significant changes to asthma management guidelines.
  Medscape Family Medicine, February 08, 2021